http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12778611

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 42467
issn 1949-2553
issueIdentifier 40
pageRange 42445-42467
publicationName Oncotarget
startingPage 42445
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_abf58a7656b0a9a213026e9ba362983b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bead761223108411212eea8d4e47ba64
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_35ed5a24190a09ad00dc5a0ccbe334f8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8217d904d9103e59b630774454f3061f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_38d3b71e9b6c85bd2a4461b0179205c0
bibliographicCitation Duquette M, Sadow PM, Husain A, Sims JN, Antonello ZA, Fischer AH, Song C, Castellanos-Rizaldos E, Makrigiorgos GM, Kurebayashi J, Nose V, Van Hummelen P, Bronson RT, Vinco M, Giordano TJ, Dias-Santagata D, Pandolfi PP, Nucera C. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget. 2015 Nov 30;6(40):42445–67. doi: 10.18632/oncotarget.6442.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fc09c9aca54beb957d1343646effe4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeaa3b6ff67205b67ab8d6fb34aca993
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64a0fb5d1c4e27259b773c4fc258a42c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cb564af9aa0a707fb0ba581eb469f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3eb18db00e82d1cdb300be4fb36780de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5813e86aebbf5f8edc4881598edf499d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97cae579e05e27cdf929e800838912b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4801-8600
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30c96a7ac9ee3db035328a7519efc00d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_571c8a182741a0a98431e520101f468b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6de878c2959beaad112bffd212c2bd8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_004a0a8cc336f99918d0a40ac475f6d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ef5dd7bc1fba26c227f89eeb19bd1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9937ac894a4047abc379cf80cdf16abc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c369d6288679bfd74c21203a749f620a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5352-5295
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1bd273581fa3fed6cf09feed1fe5d6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c413172a3bb3fbcca8a0b1338024cedb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c309663254fff210666fa372ae0a29cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59a4d19b9d721929be2d3fcf1429fdcf
date 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC4767444
https://doi.org/10.18632/oncotarget.6442
https://pubmed.ncbi.nlm.nih.gov/26636651
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
https://portal.issn.org/resource/ISSN/1949-2553
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model
discusses http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0474909
http://id.nlm.nih.gov/mesh/M0011238
http://id.nlm.nih.gov/mesh/M0558887
http://id.nlm.nih.gov/mesh/M0029573
http://id.nlm.nih.gov/mesh/M0452142
http://id.nlm.nih.gov/mesh/M0215606
http://id.nlm.nih.gov/mesh/M0020790
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D018628
http://id.nlm.nih.gov/mesh/D064549Q000235
http://id.nlm.nih.gov/mesh/D013449Q000494
http://id.nlm.nih.gov/mesh/D013964Q000235
http://id.nlm.nih.gov/mesh/D019942
http://id.nlm.nih.gov/mesh/D007211Q000494
http://id.nlm.nih.gov/mesh/D002277Q000235
http://id.nlm.nih.gov/mesh/D019008Q000235
http://id.nlm.nih.gov/mesh/D000970Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D048493Q000235
http://id.nlm.nih.gov/mesh/D014162
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D002291
http://id.nlm.nih.gov/mesh/D004797
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D064593
http://id.nlm.nih.gov/mesh/D000077484
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D016513
http://id.nlm.nih.gov/mesh/D004195
http://id.nlm.nih.gov/mesh/D009362Q000235
http://id.nlm.nih.gov/mesh/D009362Q000473
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D016688
http://id.nlm.nih.gov/mesh/D000077273
http://id.nlm.nih.gov/mesh/D020411
http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D020287
http://id.nlm.nih.gov/mesh/D015153
http://id.nlm.nih.gov/mesh/D009389
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D009154
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6655
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_086671f4507e548c21ced3a1195e1832
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c50845b337a3c11fa194521642a3ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42611257

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4170

Total number of triples: 96.